These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 1388628)
1. Dibenzo[a,g]quinolizin-8-ones: synthesis, estrogen receptor affinities, and cytostatic activity. von Angerer S; Brandl G; Mannschreck A; Weimar C; Wiegrebe W Anticancer Drug Des; 1992 Oct; 7(5):351-63. PubMed ID: 1388628 [TBL] [Abstract][Full Text] [Related]
2. Dibenzo[a,f]quinolizines: syntheses and cytostatic activity in estrogen-sensitive tumor cells. von Angerer S; Seidl E; Mannschreck A; von Angerer E; Wiegrebe W Anticancer Drug Des; 1994 Feb; 9(1):25-40. PubMed ID: 8141964 [TBL] [Abstract][Full Text] [Related]
3. 2-Phenylbenzo[b]furans: relationship between structure, estrogen receptor affinity and cytostatic activity against mammary tumor cells. Erber S; Ringshandl R; von Angerer E Anticancer Drug Des; 1991 Nov; 6(5):417-26. PubMed ID: 1764164 [TBL] [Abstract][Full Text] [Related]
4. Platinum complexes with a selective action on estrogen receptor-positive mammary tumors. von Angerer E; Birnböck H; Knebel N Anticancer Drug Des; 1989 Jun; 4(1):21-35. PubMed ID: 2757751 [TBL] [Abstract][Full Text] [Related]
5. Cytostatic and cytotoxic action of Z-1, 1-dichloro-2,3-diphenylcyclopropane in three human breast cancer cell lines. ter Haar E; Day BW Anticancer Res; 1996; 16(3A):1107-15. PubMed ID: 8702221 [TBL] [Abstract][Full Text] [Related]
6. 6-Alkyl-12-formylindolo[2,1-a]isoquinolines. Syntheses, estrogen receptor binding affinities, and stereospecific cytostatic activity. Polossek T; Ambros R; von Angerer S; Brandl G; Mannschreck A; von Angerer E J Med Chem; 1992 Sep; 35(19):3537-47. PubMed ID: 1404234 [TBL] [Abstract][Full Text] [Related]
7. Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships. Connor K; Ramamoorthy K; Moore M; Mustain M; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P Toxicol Appl Pharmacol; 1997 Jul; 145(1):111-23. PubMed ID: 9221830 [TBL] [Abstract][Full Text] [Related]
8. Steroidal affinity labels of the estrogen receptor. 3. Estradiol 11 beta-n-alkyl derivatives bearing a terminal electrophilic group: antiestrogenic and cytotoxic properties. Lobaccaro C; Pons JF; Duchesne MJ; Auzou G; Pons M; Nique F; Teutsch G; Borgna JL J Med Chem; 1997 Jul; 40(14):2217-27. PubMed ID: 9216841 [TBL] [Abstract][Full Text] [Related]
9. Antiestrogenically active 1,1,2-tris(4-hydroxyphenyl)alkenes without basic side chain: synthesis and biological activity. Lubczyk V; Bachmann H; Gust R J Med Chem; 2003 Apr; 46(8):1484-91. PubMed ID: 12672249 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines. Top S; Vessières A; Leclercq G; Quivy J; Tang J; Vaissermann J; Huché M; Jaouen G Chemistry; 2003 Nov; 9(21):5223-36. PubMed ID: 14613131 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of basic side chain derivatives of Analog II as pure antiestrogens and antitumor agents. Magarian RA; Avor KS; Overacre LB; Kunchandy J; Paxton TR Anticancer Drug Des; 1995 Jun; 10(4):311-31. PubMed ID: 7786397 [TBL] [Abstract][Full Text] [Related]
12. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis. Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of B-, C-, and D-ring-substituted estradiol carboxylic acid esters as locally active estrogens. Labaree DC; Zhang JX; Harris HA; O'Connor C; Reynolds TY; Hochberg RB J Med Chem; 2003 May; 46(10):1886-904. PubMed ID: 12723952 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of 4-(hydroxyalkyl)estradiols and related compounds. Lovely CJ; Bhat AS; Coughenour HD; Gilbert NE; Brueggemeier RW J Med Chem; 1997 Nov; 40(23):3756-64. PubMed ID: 9371241 [TBL] [Abstract][Full Text] [Related]
15. Novel 5-aminoflavone derivatives as specific antitumor agents in breast cancer. Akama T; Shida Y; Sugaya T; Ishida H; Gomi K; Kasai M J Med Chem; 1996 Aug; 39(18):3461-9. PubMed ID: 8784443 [TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity. Murphy CS; Parker CJ; McCague R; Jordan VC Mol Pharmacol; 1991 Mar; 39(3):421-8. PubMed ID: 2005879 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of tubulin polymerization by 5,6-dihydroindolo[2,1-alpha]isoquinoline derivatives. Goldbrunner M; Loidl G; Polossek T; Mannschreck A; von Angerer E J Med Chem; 1997 Oct; 40(22):3524-33. PubMed ID: 9357519 [TBL] [Abstract][Full Text] [Related]
18. Induction of the estrogen specific mitogenic response of MCF-7 cells by selected analogues of estradiol-17 beta: a 3D QSAR study. Wiese TE; Polin LA; Palomino E; Brooks SC J Med Chem; 1997 Oct; 40(22):3659-69. PubMed ID: 9357533 [TBL] [Abstract][Full Text] [Related]
19. 3-Alkyl-2-phenylbenzo[b]thiophenes: nonsteroidal estrogen antagonists with mammary tumor inhibiting activity. von Angerer E; Erber S J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):557-62. PubMed ID: 1562527 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of ellipticine-estradiol conjugates. Devraj R; Barrett JF; Fernandez JA; Katzenellenbogen JA; Cushman M J Med Chem; 1996 Aug; 39(17):3367-74. PubMed ID: 8765520 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]